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The recent development of deep brain stimulation (DBS) of the pedunculopontine
nucleus (PPN) for the treatment of parkinsonian patients, particularly those in
advanced stages with axial symptoms, has ignited interest into the study of this
brain nucleus. In contrast to the extensively studied alterations of neural activity
that occur in the basal ganglia in Parkinson’s disease (PD), our understanding of
the activity of the PPN remains insufficient. In recent years, however, a series
of studies recording oscillatory activity in the PPN of parkinsonian patients have
made important findings. Here, we briefly review recent studies that explore the
different kinds of oscillations observed in the PPN of parkinsonian patients, and
how they underlie the pathophysiology of PD and the efficacy of PPN-DBS in these
disorders.
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Introduction
The use of single unit or action potential recordings to examine increases or decreases in neural
firing does not fully capture the dysfunction of the basal ganglia in Parkinson’s disease (PD).
In recent years, the use of local field potential (LFP) recordings has made a resurgence in the
investigation of the pathophysiology of Parkinsonian and other movement disorders. LFP, similar
to EEG, is a kind of oscillatory activities, which is classified by the oscillatory frequency. Generally,
LFP is divided into five bands: delta band (1–3 Hz), theta band (4–7 Hz), alpha band (8–13 Hz),
beta band (14–30 Hz), and gamma band (>30 Hz). The boundaries of these bands may be a little
different in studies. Patients’ LFP is recorded through the electrode used for deep brain stimulation
(DBS) after electrode implantation and before connection to the stimulator. In animals, special
metal microelectrodes are planted into brain to record LFP. Several bands of oscillatory activities
have been detected in the cortico-basal ganglia circuits, including in the subthalamic nucleus
(STN) and the internal segment of the globus pallidus (Brown, 2003; Boraud et al., 2005; Gatev
et al., 2006; Uhlhaas and Singer, 2006; Eusebio and Brown, 2007). Among these, aberrant beta
band oscillations have been deemed to be one of the most important findings in the brain of
PD patients (Levy et al., 2002; Fogelson et al., 2006; Weinberger et al., 2006; Chen et al., 2007;
Hammond et al., 2007). These beta band abnormalities are believed to have anti-kinetic effects,
and are likely to be responsible for some PD symptoms (Brown et al., 2001; Fogelson et al., 2006).
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In advanced stages of PD, axial symptoms such as severe
gait and postural impairments that are not ameliorated by
levodopa and STN stimulation present difficult obstacles for
many patients. To relieve these symptoms, targeting the
pedunculopontine nucleus (PPN) with DBS holds some promise
(Moro et al., 2010; Thevathasan et al., 2011; Wilcox et al.,
2011; Morita et al., 2014). Although the PPN generally
is not considered part of the cortico-basal ganglia loop,
there are extensive reciprocal connections between the PPN
and the basal ganglia. Therefore, the question arises of
whether the PPN may exhibit the same oscillatory activity
as the basal ganglia in PD. Also, what is the relationship
between PPN oscillations and the pathophysiology of PD?
How are PPN oscillations altered with DBS treatment?
These are the questions that will be discussed in this
review.
Overview of Oscillations in the PPN
Activity in the alpha frequency has been the most noticeable
oscillatory activity recorded in the PPN, first recorded in
parkinsonian patients by Androulidakis et al. (2008a,b).
Although alpha band oscillations have drawn less attention
in studies of the basal ganglia, these activities likely play a
pivotal role in the function of the PPN. For example, alpha band
power increases significantly following treatment with levodopa
(Androulidakis et al., 2008b; Fraix et al., 2013) and correlates
with gait performance in PD patients (Thevathasan et al., 2012;
Tattersall et al., 2014). These studies suggest that activity in the
alpha band plays a physiological function in the PPN, and is
pathologically attenuated in PD.
Unlike findings in the cortical-basal ganglia loop, there
currently exists no consensus as to the importance of beta
band PPN activity in PD. A number of studies have shown
that dopaminergic medication has a suppressive effect upon
beta activity in the PPN, implying that this activity may
contribute to akinesia in PD (Thevathasan et al., 2012; Fraix
et al., 2013). Other studies have found quite the contrary,
however. For example, beta oscillations in the PPN were
shown to decrease in the absence of medication, but increase
in the presence of medication, in patients making voluntary
movements. In this study, beta coherence between the midline
prefrontal region and the PPN was only found in the medicated
state (Tsang et al., 2010). Thus, beta rhythms may have a
different functional significance in the PPN compared with
the basal ganglia, in that these oscillations could be pro-
kinetic.
Topological differences appear to exist between the alpha and
beta oscillations of the caudal vs. the rostral PPN. In parkinsonian
patients, alpha oscillations represented the main frequency in the
caudal subregion of the PPN, while beta oscillations predominate
in the rostral subregion (Figure 1A; Weinberger et al., 2008;
Thevathasan et al., 2012; Tattersall et al., 2014).
Theta and gamma band oscillations have also been recorded
in the PPN (Shimamoto et al., 2010; Tsang et al., 2010;
Fraix et al., 2013; Valencia et al., 2014; Lau et al., 2015).
In the basal ganglia, theta activity has been suggested to
underlie parkinsonian tremor, which appears and disappears in
synchrony with muscle tremor (Stein and Bar-Gad, 2013). In
the PPN, theta oscillations may be involved in the feedback
of sensory information between the PPN and the sensorimotor
cortices (will be discussed below; Tsang et al., 2010). Gamma
oscillations were first reported in the PPN of parkinsonian
patients by Fraix et al., who proposed that their functional
impact might be similar to beta oscillations (Fraix et al.,
2013). This certainly requires further investigation. Table 1
shows different studies looking at oscillatory activity in the
PPN. The major oscillations in the PPN and their functional
characteristics are summarized in Figure 1D and will be
discussed below.
TABLE 1 | Different studies looking at oscillatory activity in the PPN.
Study Subjects Frequency band Findings or speculations
Androulidakis et al. (2008a) 1 patient Alpha (7–11 Hz) Play a physiological role
Androulidakis et al. (2008b) 6 patients Alpha (7–11 Hz) Play a physiological role
Related to attentional processes
Weinberger et al. (2008) 7 patients Beta (15–30 Hz) Help to guide electrode implantation
Tsang et al. (2010) 7 patients Theta (6–10 Hz) Involved in sensory feedback
Beta (14–30 Hz) May be pro-kinetic
Thevathasan et al. (2012) 7 patients Alpha (7–10 Hz) Correlate with gait performance
Suppress task irrelevant distraction
Mainly in the caudal-PPN
Beta (17.3–28.5 Hz) Mainly in the rostral-PPN
Fraix et al. (2013) 7 patients Alpha (5–12 Hz) Pro-kinetic
Beta (13–35 Hz) Anti-kinetic
Gamma (>35 Hz) Anti-kinetic
Tattersall et al. (2014) 11 patients Alpha (6–12 Hz) Mainly in the caudal-PPN
Beta (12–30 Hz) Mainly in the rostral-PPN
Lau et al. (2015) 6 patients Alpha (8–13 Hz) Spatially localized within PPN
Beta (13–30 Hz) Spatially localized within PPN
Valencia et al. (2014) Rats Alpha (8–12 Hz) Altered connectivity between motor cortex and the PPN
Gamma (30–70 Hz)
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FIGURE 1 | The anatomy (location and connections) of the
pedunculopontine nucleus (PPN) and the major oscillations in the PPN
and their functional characteristics. (A) The location of the PPN in the
human brain. Alpha oscillations mainly present in the caudal subregion of the
PPN, beta oscillations predominantly in the rostral subregion. (B) The major
efferent and afferent pathways of the PPN to the basal ganglia and other motor
structures in the human brain. Neurons in the rostral subregion mainly express
GABA, while neurons in the caudal subregion are primarily cholinergic. Adapted
from Jenkinson et al. (2009). (C) The major efferent and afferent pathways of the
PPTg to the basal ganglia and other motor structures in the rat brain. (D) The
major oscillations in the PPN and their functional characteristics. Alpha band
promote gait performance by modulating attention processes. Enhanced beta
band may result in akinesia. PPN-DBS may affect these two bands to improve
symptoms. Theta band is involved in sensory feedback. SNc, substantia nigra
compacta; SNr, substantia nigra reticular; GPi/EP, internal globus pallidus;
GPm, medial pallidum; STN, subthalamic nucleus; Cd/CPu, caudate nucleus
and putamen; Thal, thalamus; Pt, paratenial nucleus; GABA, gamma
aminobutyric acid; Ach, acetylcholine.
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Implications of PPN Oscillations for PD
Alpha band power has been correlated with gait performance
in parkinsonian patients, and oscillations at this frequency are
increased after application of levodopa (Thevathasan et al., 2012;
Fraix et al., 2013). Given this, one may wonder how alpha
activity in the PPN might relate to the amelioration of axial
symptoms. Alpha activity is considered to play a vital part in
attention and in the allocation of processing resources in the
brain (Klimesch, 1999; Palva and Palva, 2007). Increases in
alpha activity may indicate the suppression of a distracting or
task-irrelevant process, concomitant with the increased ability
to focus attention on an important task (Ward, 2003; Jensen
and Mazaheri, 2010). For example, alpha power increases with
memory load during memory tasks, reflecting the individual’s
efforts to suppress distraction (Jensen et al., 2002). In the motor
system, alpha activity is associated with the suppression of
irrelevant processes in order to allow the smooth execution of
motor programs (Pfurtscheller and Neuper, 1994; Suffczynski
et al., 2001). Impairments in attentional function are common
in parkinsonian patients (Wu and Hallett, 2008). Moreover,
patients with axial symptoms (for example, gait freezing) are
found to suffer more serious attentional impairments than
those without Amboni et al. (2008) and Yogev-Seligmann
et al. (2008). Thus, gait freezing is thought to be related to
attentional deficits (Giladi and Hausdorff, 2006; Okuma, 2006).
The results of a recent study on PPN-DBS of PD patients
suggested that attentional augmentation can be ‘‘one possible
mechanism to improve motor action and gait in patients
with parkinsonian disorders’’ (Fischer et al., 2015). As part
of the reticular activating system, the PPN could modulate
attention via alpha oscillations to facilitate gait performance
(Figure 1D).
Alpha oscillations have been recorded in a relatively caudal
region of the PPN (Thevathasan et al., 2012), a region shown by
animal studies to be rich in cholinergic neurons (Figures 1A,B;
Martinez-Gonzalez et al., 2011). These neurons project widely,
ranging from the cortex to locomotor centers (Figures 1B,C;
Skinner et al., 1990; Mena-Segovia et al., 2008). Loss of
cholinergic neurons in the PPN has been observed in PD, and this
is thought to be associated with the gait and postural disorders of
parkinsonian patients (Karachi et al., 2010; Grabli et al., 2013).
Patients with a less severe loss of PPN cholinergic neurons
may have better clinical outcomes with PPN-DBS therapy (Lau
et al., 2015). Presumably, the dysfunction of cholinergic neurons
might reduce the positive effects of PPN alpha activity in
the modulation of attention processes, thereby leading to gait
problems.
Theta rhythms in the PPN are hypothesized to be involved
in the functional impact of sensory feedback, and not with
other functions ascribed to the alpha band (Tsang et al.,
2010). Based on animal studies, the PPN may be particularly
involved in the sorting of sensory information for movement
planning and performance (Winn, 2006). Studies of the phase
relationship in theta band coherence between the cortex and
PPN reveal that the sensorimotor cortex is temporally ahead of
the PPN in motor planning, but is later in motor performing,
suggesting that the cortex may drive the PPN in the phase of
planning, then sensory information fed back to the cortex via
the PPN to facilitate motor performance (Tsang et al., 2010).
Coherence in theta activity has been observed in other related
encephalic regions, such as the ipsilateral sensorimotor cortex
and the ventral thalamus, areas that are suggested to form
a system connecting related brain areas for the purpose of
continuously monitoring sensory information (Nicolelis et al.,
1995; Marsden et al., 2000). Thus, theta activity in the PPN may
indicate that this region is part of this sensory feedback system
(Figure 1D).
Within the PPN, neurons in the rostral subregion mainly
express gamma aminobutyric acid (GABA) and are inhibitory,
whereas neurons in the caudal subregion are primarily
glutamatergic and cholinergic (Martinez-Gonzalez et al., 2011).
These two regions have distinct projection patterns that connect
them to disparate brain structures. Robust interconnections exist
between neurons in the rostral PPN and the basal ganglia (Mena-
Segovia et al., 2004; Martinez-Gonzalez et al., 2011), whereas
caudal PPN neurons mainly connect with cortical and locomotor
centers such as the gait generator in the spinal cord (Figure 1B;
Skinner et al., 1990; Mena-Segovia et al., 2008). This neuronal
heterogeneity in the PPN likely underlies the differences in
oscillatory activity between PPN subregions. For example, the
beta activity recorded in the rostral subregion of the PPN is
consistent with reciprocal connections to the basal ganglia, which
exhibit excessive beta activity in PD. In the caudal PPN, alpha
activity appears to be in coherence with cortical activity and
relevant to locomotion.
The oscillatory topography discussed above suggests that the
depth of recording electrodes along the rostro-caudal axis will
have a significant effect on the type of dominant oscillatory
patterns recorded in the PPN. This is one explanation for
the discrepancy between studies that have recorded different
oscillations in parkinsonian patients, which could lead to
inconsistent interpretations of beta activity. The differing views
regarding the importance of beta band oscillations in the PPN,
however, likely also originate from additional factors such as
small sample size, patient heterogeneity, and the diversity of
analysis methods. According to animal data, increased beta
oscillatory activity in the basal ganglia can be transmitted
downstream to the PPN (Aravamuthan et al., 2008). Accordingly,
from the current literature, it seems likely that beta activity in the
human PPN, as in the basal ganglia, could contribute to akinesia
in PD (Figure 1D), but more studies are needed.
PPN Oscillations and PPN-DBS
Although DBS has been used for decades for the treatment
of PD and other movement disorders, the precise mechanisms
underlying the efficacy of this therapy remain unclear. One
speculation is that high frequency DBS of the STN inhibits
neurons by focal depolarization, thereby blockading abnormal
discharges from the basal ganglia (Filali et al., 2004; Welter
et al., 2004; Chang et al., 2008). While this may be consistent
with the classical Albin/Delong model (A widely accepted model
of basal ganglia function based on the dominant anatomical
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connections of basal ganglia nuclei and their neurochemistry;
Albin et al., 1989; DeLong, 1990), some doubt remains. For
example, the electrical pulses used in DBS are thought to be too
brief to blockade basal ganglia activity. Additionally, the long
term suppression of basal ganglia activity should lead to the
death of neurons and increased gliosis, yet these phenomena
have not been observed in autopsies of DBS patients (Burbaud
et al., 2002). A blockading effect is unlikely to be the mechanism
underlying the efficacy of DBS in the PPN, since the low
frequency stimulation used in this paradigm would not produce
inhibitory effects.
Rather, it is possible that DBS of the PPN directly drives
its activity to benefit parkinsonian states. The low frequency
stimulus is the most effective for symptom relief in PPN-
DBS treatment (Mazzone et al., 2005), and this paradigm is
generally considered to increase neuronal activity (Aravamuthan
et al., 2008). The power of alpha oscillations recorded in
the PPN of parkinsonian patients indicates that this activity
may have a physiological function, since it is pathologically
attenuated in PD. Therefore, low frequency stimulation of the
PPN may drive the neurons and simulate the inherent alpha
activity. This concept is supported by the interesting finding
that parkinsonian patients who underwent PPN-DBS obtained
the best therapeutic effect when the stimulation electrode was
placed in the site of maximal alpha activity, namely, the
caudal PPN (Thevathasan et al., 2012). Furthermore, non-
human primate research suggests that the PPN is over-inhibited
in parkinsonian states (Matsumura and Kojima, 2001; Nandi
et al., 2002). Accordingly, the ability of DBS to drive the
PPN is a likely mechanism for its therapeutic effects in PD
(Figure 1D).
From recent studies, based upon recordings of pathological
oscillatory activity (beta oscillations) in the cortical-basal ganglia
loop in parkinsonian patients, it has been suggested that DBS
may exert beneficial effects via the disruption of this aberrant
activity. In the PPN, it is possible that DBS may exert its positive
effects in this manner (Figure 1D). It has been suggested that
pathological beta oscillations recorded in the PPN could have
been transmitted downstream from the basal ganglia. Moreover,
low frequency PPN-DBS was shown to reduce beta frequency
activity in the STN of 6-OHDA lesioned rats (Alam et al., 2012).
Another mechanism, one that involves spike timing, could
underlie the therapeutic effects of PPN-DBS. Studies of the
relationship between PPN spiking and LFP activity found that
the PPN spike timing changed significantly following 6-OHDA
lesioning in rats. In intact rats, PPN firing tended to occur at
the troughs of LFP oscillations, and this neuronal firing became
peak-locked in the lesioned rats (Aravamuthan et al., 2008).
Based on this evidence, it is possible that PPN-DBS affects PPN
spike-timing relationship to normalize activity.
As mentioned, alpha and beta oscillations in the PPN are
spatially localized (Thevathasan et al., 2012; Lau et al., 2015);
thus this topographical arrangement can provide a guide for
DBS electrode implantation. The finding that stimulation at
the position of maximal alpha activity results in the most
effective amelioration of symptoms suggests that the site of
stimulation in the PPN is a crucial factor affecting therapeutic
outcomes, one that merits more attention. Along these lines,
a recent study on parkinsonian rats found distinct effects of
the pedunculopontine tegmental nucleus (PPTg, the equivalent
to the human PPN) DBS at different sites of stimulation, and
emphasized ‘‘the critical importance of intra-PPTgDBS location’’
(Gut and Winn, 2015). The PPN is a heterogeneous structure
in the brainstem that presents with an uncertainty boundary,
and which is involved in multiple functions including cortical
arousal, the control of behavioral processing, and locomotion
(Ros et al., 2010; Benarroch, 2013). Different subregions in the
PPN may have different functions (Martinez-Gonzalez et al.,
2011). With regard to motor function, some processes may
be closely associated with the cortico-basal ganglia loop, while
others have connections with locomotion centers such as the gait
generator in the spinal cord. The function of each subregion as
well as their interconnections merits further study.
Conclusion
Studies that record oscillatory activity in the PPN have provided
a great deal of information regarding the pathophysiology of
PD and the mechanisms underlying the effects of PPN-DBS.
Alpha activity is considered to be important in the PPN,
where it may modulate attentional processes to improve gait
performance in parkinsonian patients. DBS of the PPN could
alleviate gait symptoms by driving PPN neurons and thereby
affecting alpha oscillations. Nevertheless, PPN-DBS therapy
remains experimental, and only a small number of patients are
available to study. Large multicenter clinical trials are needed to
best study the efficacy of PPN-DBS in PD. At the same time,
more animal research would greatly supplement human studies
by more mechanistic examination of this enigmatic brain region.
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